Cleared Traditional

K222330 - The Heart Seat

K222330 is an FDA 510(k) clearance for The Heart Seat, manufactured by Casana Care, Inc.. The device is a Class 2 Cardiovascular device with product code MWI cleared through the Traditional 510(k) pathway after a 265-day FDA review.

K222330 · Casana Care, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2023
Decision
265d
Days
Class 2
Risk

K222330 is an FDA 510(k) clearance for the The Heart Seat. Classified as Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) (product code MWI), Class II - Special Controls.

Submitted by Casana Care, Inc. (Rochester, US). The FDA issued a Cleared decision on April 24, 2023 after a review of 265 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Casana Care, Inc. devices

FDA 510(k) Submission Details - K222330

510(k) Number K222330 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 02, 2022
Decision Date April 24, 2023
Days to Decision 265 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
140d slower than avg
Panel avg: 125d · This submission: 265d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MWI Device Classification - Class 2, Special Controls

Product Code MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Biologics Consulting
Donna-Bea Tillman

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)

All 153
Devices cleared under the same product code (MWI) and FDA review panel - the closest regulatory comparables to K222330.
Portrait™ Central Viewer Application (Portrait CV A01), Portrait ™ Core Services (Portrait CSS01), Portrait™ Clinical Alarming Unit (Portrait CAU01)
K230626 · Ge Medical Systems Information Technologies, Inc. · Aug 2023
ARC Intensive Care Information System (ARC System)
K220117 · Ordinatrum Solutions · Jun 2023
Huma RPM (RPM)
K230214 · Medopad, Inc. · Jun 2023
Radical-7 Pulse CO-Oximeter and Accessories, Rad-97 and Accessories
K212161 · Masimo Corporation · Mar 2023
VS 8 Vital Signs Monitor, VS 8A Vital Signs Monitor, VS 9 Vital Signs Monitor
K221267 · Shenzhen Mindray Bio-Meidcal Electronics Co., Ltd. · Dec 2022
Accutorr 3 Vital Signs Monitor, Rosebud Vital Signs Monitor
K221113 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Dec 2022